Upgrade to SI Premium - Free Trial

Protalix BioTherapeutics (PLX)

1.98 -0.01 (0.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/17/26)

Latest Headlines

Form 8-K Protalix BioTherapeutics For: May 21 May 21, 2026 7:03 AM - SEC Filing Form 10-Q Protalix BioTherapeutics For: Mar 31 May 13, 2026 7:07 AM - SEC Filing Form 8-K Protalix BioTherapeutics For: May 13 May 13, 2026 6:57 AM - SEC Filing Protalix BioTherapeutics (PLX) Tops Q1 EPS by 18c ; Offers Guidance May 13, 2026 6:52 AM - StreetInsider Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results May 13, 2026 6:50 AM - PR NewsWire Protalix BioTherapeutics to Announce First Quarter 2026 Financial Results and Business Update on May 13, 2026 May 6, 2026 6:50 AM - PR NewsWire Form ARS Protalix BioTherapeutics For: Dec 31 April 30, 2026 4:37 PM - SEC Filing Form DEF 14A Protalix BioTherapeutics For: Jun 25 April 30, 2026 4:32 PM - SEC Filing Form 3/A Protalix BioTherapeutics For: Aug 24 Filed by: Mamlok Gilad April 27, 2026 5:00 PM - SEC Filing Form SCHEDULE 13G/A Protalix BioTherapeutics Filed by: MAK Capital Fund LP March 30, 2026 5:35 PM - SEC Filing Form 10-K Protalix BioTherapeutics For: Dec 31 March 18, 2026 7:14 AM - SEC Filing Form 8-K Protalix BioTherapeutics For: Mar 18 March 18, 2026 6:57 AM - SEC Filing Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08 March 18, 2026 6:55 AM - StreetInsider Protalix BioTherapeutics Reports Fiscal Year 2025 Financial and Business Results March 18, 2026 6:50 AM - PR NewsWire Protalix BioTherapeutics to Announce Fiscal Year 2025 Financial Results and Business Update on March 18, 2026 March 11, 2026 6:50 AM - PR NewsWire Full Article List